LifeSci Search

Happy Holidays from all of us at LifeSci Search! As we wind down another year, we'd like to take a moment to appreciate the milestones we've achieved and the partnerships that have flourished. We're thankful for the continued dedication of our team and the unwavering support from our clients and partners. 💬 We'd love to hear your 2024 highlights! #HappyHolidays #YearInReview #LifeSciences #Gratitude

Join LifeSci Search's John Spencer and Molly Robb at the 43rd Annual J.P. Morgan Healthcare Conference, Jan 13-16, 2025, in San Francisco. We're excited to engage in crucial industry conversations and explore innovative opportunities in healthcare. 💬👇 Will we see you there? Drop a comment below if you'll be attending! Looking forward to connecting and driving forward the future of healthcare together. #Healthcare #LifeSciences #JPMorgan2025

We’re pleased to announce Deyaa Adib, MD ’s placement as Chief Medical Officer at AffyImmune Therapeutics! Deyaa brings robust experience in oncology research and development with a focus on clinical-stage engineered T-cell therapies. At AffyImmune, he will propel the development of novel T-cell therapies aimed at various cancers. AffyImmune is at the forefront of immune oncology, driving innovations that target significant unmet medical needs in cancer care. Kudos to Molly Robb for guiding this exceptional hire. Read more about our placements: https://lnkd.in/ehyeFP9e Press release: https://lnkd.in/e_5gkbEt #LifeSciences #ExecutiveSearch #Oncology

Congratulations to Matthew Ellis on his new role as SVP of Clinical Development, Oncology at Guardant Health! Matthew joins from AstraZeneca, where he significantly advanced oncology treatments into early-phase trials and led the creation of the Cancer Biomarker Development program. Guardant Health is a leader in non-invasive cancer diagnostics using genomic data to drive better patient outcomes. A special thanks to John Spencer and Alexis Darby from our team for their roles in this strategic placement. Discover our client success stories: https://lnkd.in/ehyeFP9e #LifeSciences #ExecutiveSearch #Oncology

ArrePath, a venture-backed, preclinical, seed-stage company that has built a novel machine learning (ML)-based imaging platform for anti-infective drug discovery, required a President and CEO who could steer the company through the complex Infectious Disease market conditions and leverage the innovative drug discovery platform to develop new mechanisms of action (MoA) for innovative drugs to fight antibiotic microbial resistance (AMR).   Our President and CEO search targeted experienced leaders in the sector, identifying over 100 potential candidates and closely working with the Search Committee to narrow our candidate pool to nine exceptional interview finalists. Kevin Krause was hired as the new President, CEO, and Board Member. He brings over 25 years of experience in research, clinical development, commercialization and corporate development in the biotech industry. Kevin's leadership is set to advance ArrePath's mission to develop next-generation antimicrobials significantly. Read the official press release on his appointment here: https://lnkd.in/eZ2EbeAq Discover more about our approach to executive search: https://lnkd.in/ehyeFP9e #AntimicrobialResistance #AMR #InfectiousDisease #ExecutiveSearch #ExecutiveRecruitment #DrugDevelopment

🦃 This Thanksgiving, we are incredibly grateful for the dynamic community we serve—clients, candidates, partners, and our dedicated team. In the spirit of this holiday, collaboration continues to sustain our growth. Thank you for being a vital part of our journey. Wishing everyone a Thanksgiving filled with health and happiness. #Thanksgiving #LifeSciences #Gratitude

💜 As we near the end of National Epilepsy Awareness Month, remember that epilepsy impacts millions globally, demanding ongoing research and advocacy for better treatments. Let's keep the momentum going by supporting epilepsy research and education. Get involved and learn more at https://lnkd.in/excibreV #EpilepsyAwareness #ShareYourPurplePower

🧠 As National Alzheimer's Awareness Month comes to a close, let's reflect on the progress and the challenges that remain in tackling Alzheimer's. With millions affected worldwide, focusing on innovative research and comprehensive care strategies is crucial. Continue supporting Alzheimer's research and care at https://lnkd.in/eQi2B76y #Alzheimers #EndAlzheimers #AlzheimersAwarenessMonth

International Survivors of Suicide Loss Day (November 23rd) is a moment to reflect, support, and connect with others who share the journey of loss and healing. It's a day to remind those affected that they are not alone. Participate in events and share your story to help extend support to every survivor. Details at https://lnkd.in/dYK-pG7 #SurvivorDay #MentalHealthSupport

🌟 Congratulations to Kevin Krause on his new role as President, Chief Executive Officer, and Board Member at ArrePath! Kevin brings over two decades of deep expertise in the #biotech and #pharmaceutical industries, particularly in the antibacterial space. As the former CSO of AN2 Therapeutics, he advanced a pre-clinical asset to a multi-national Phase 2/3 study, showcasing his capability to navigate complex clinical landscapes and lead successful IPOs. Learn more in the official release: https://lnkd.in/eZ2EbeAq ArrePath is dedicated to combatting drug-resistant infections with a cutting-edge ML-based platform that rapidly identifies potent anti-infectives. Founded on innovative research published in Cell, ArrePath is poised to advance infectious disease treatment significantly. Thank you to Molly Robb, Jennifer Phillips, Emily Bravaco, and Cari Maguire from the LifeSci Search team for their hard work on this placement. Discover more about our successful placements and how we can assist your search: https://lnkd.in/ehyeFP9e #LifeSciences #ExecutiveSearch